CDK12 promotes tumor initiation through regulating cancer stem cells (CSCs) or affecting the genes which are necessary to activate downstream pathways such as ErbB-PI3K-AKT (Protein Kinase B) or WNT-signaling cascades [59]. This evidence concerns the gene AKT1 and neoplasm.